Are Aromatase Inhibitors Associated with Higher Myocardial Infarction Risk in Breast Cancer Patients? A Medicare Population ‐Based Study
ConclusionsIn this SEER ‐Medicare based population study, there were no significant differences in the risk of MI between AI and tamoxifen users after adjustment for known risk factors.
Source: Clinical Cardiology - Category: Cardiology Authors: Sailaja Kamaraju,
Yushu Shi,
Elizabeth Smith,
Ann B. Nattinger,
Purushottam Laud,
Joan Neuner Tags: CLINICAL INVESTIGATIONS Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Congestive Heart Failure | Databases & Libraries | Diabetes | Endocrinology | Epidemiology | Heart | Heart Attack | Heart Disease | Heart Failure | Medicare | Peripheral Vascular Disease (PVD) | Study | Tamoxifen | Women